drugset / Trial / NCT00357383
Study of the Ocular Safety After Repeated Instillations of T1225 1% or 1.5% Eye Drops in Healthy Volunteers
RandomizedParallel-groupDouble-blindTreatment
Summary
To evaluate the ocular tolerance of T1225 1% and 1.5% eye drops versus vehicle after one instillation twice-daily (morning and evening), in one eye, during 3 days (from Day 0 to Day 2). To assess azithromycin tear, conjunctiva and plasmatic concentrations, after a 3-day treatment period
Timeline
- Start
- 2002-10
- Primary completion
- —
- Completion
- 2002-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azithromycin | Small molecule | 1 % | Other |
| Subject | Azithromycin | Small molecule | 1.5 % | Other |